Business Description
Touyun Biotech Group Ltd
NAICS : 339999
ISIN : BMG215AV1072
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.09 | |||||
Debt-to-Equity | -453.9 | |||||
Debt-to-EBITDA | -1.45 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -2.62 | |||||
Beneish M-Score | -3.39 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -6.9 | |||||
3-Year EBITDA Growth Rate | 3.1 | |||||
3-Year EPS without NRI Growth Rate | 29.3 | |||||
3-Year FCF Growth Rate | 45.6 | |||||
3-Year Book Growth Rate | -24.8 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 64.87 | |||||
9-Day RSI | 59.18 | |||||
14-Day RSI | 56.79 | |||||
6-1 Month Momentum % | -57.14 | |||||
12-1 Month Momentum % | -63.16 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.43 | |||||
Quick Ratio | 0.39 | |||||
Cash Ratio | 0.09 | |||||
Days Inventory | 72.27 | |||||
Days Sales Outstanding | 61.16 | |||||
Days Payable | 77.52 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.6 | |||||
Shareholder Yield % | -6.22 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 28.5 | |||||
Operating Margin % | -43.79 | |||||
Net Margin % | -135.39 | |||||
FCF Margin % | 18.49 | |||||
ROE % | -179.85 | |||||
ROA % | -35.89 | |||||
ROIC % | -11.86 | |||||
ROC (Joel Greenblatt) % | -74.25 | |||||
ROCE % | -70.96 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 3.37 | |||||
PB Ratio | 2.67 | |||||
Price-to-Tangible-Book | 2.67 | |||||
Price-to-Free-Cash-Flow | 18.47 | |||||
Price-to-Operating-Cash-Flow | 13.34 | |||||
EV-to-EBIT | -3.75 | |||||
EV-to-EBITDA | -3.75 | |||||
EV-to-Revenue | 5.01 | |||||
EV-to-FCF | 27.08 | |||||
Earnings Yield (Greenblatt) % | -26.67 | |||||
FCF Yield % | 5.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Touyun Biotech Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 198.64 | ||
EPS (TTM) (HK$) | -0.096 | ||
Beta | 0.34 | ||
Volatility % | 59.72 | ||
14-Day RSI | 56.79 | ||
14-Day ATR (HK$) | 0.013866 | ||
20-Day SMA (HK$) | 0.22005 | ||
12-1 Month Momentum % | -63.16 | ||
52-Week Range (HK$) | 0.131 - 0.68 | ||
Shares Outstanding (Mil) | 2,805.95 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Touyun Biotech Group Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Touyun Biotech Group Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Touyun Biotech Group Ltd Frequently Asked Questions
What is Touyun Biotech Group Ltd(HKSE:01332)'s stock price today?
When is next earnings date of Touyun Biotech Group Ltd(HKSE:01332)?
Does Touyun Biotech Group Ltd(HKSE:01332) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |